1. Stocks
  2. KalVista Pharmaceuticals Inc
  3. Swot
swot-logo

KalVista Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

KalVista Pharmaceuticals Inc has 9 Strengths, 9 Weaknesses, 4 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over the Quarter (3 Months)

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Month

Company with Low Debt

Stock with Low PE (PE < = 10)

RSI indicating price strength

Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Top Losers

Low Piotroski Score : Companies with weak financials

Declining Net Cash Flow : Companies not able to generate net cash

Annual net profit declining for last 2 years

Declining profits every quarter for the past 2 quarters

Top Losers

Mutual Funds Increased Shareholding in Past Month

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months

Promoters increasing shareholding QoQ

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks